The causes of raised serum alkaline phosphatase were determined prospectively in a consecutive series of 2884 acute medical admissions. Diagnoses were established by pre-defined clinico-pathological criteria. Two hundred and four patients had hyperphosphatasaemia. Liver and bone disease accounted for only 98 (48%) of the established diagnoses. The diagnosis was not established in 31 (15%). Transient hyperphosphatasaemia occurred in 66 (32.4%) cases. In 25 ofthese patients (12% ofthe total) an acute infection was the sole illness identified. In this infected group, the isoenzyme type was predominantly hepatic, although jaundice occurred in only 3 patients. Discriminant analysis revealed that this group was characterized by haematological and biochemical features of an acute phase response.
Introduction
The causes of raised serum alkaline phosphatase (ALP) are well documented and widely known. The most frequent causes of raised ALP are liver disease, bone disease and hepatic congestion secondary to heart failure.1'2 Often, however, the cause of hyperphosphatasaemia is not found and the liver fraction of serum alkaline phosphatase may be elevated without clinically apparent liver disease. 3 Raised serum alkaline phosphatase may be associated with acute infection but descriptions of this phenomenon are confined to occasional case reports4 or selected groups (such as the elderly).5 Transient hyperphosphatasaemia, in the absence ofjaundice and in association with acute infection, is shown, in this study, to occur commonly in a series of acute general medical admissions. It is not a well recognized cause of hyperphosphatasaemia in adults and its prevalence in acutely ill medical patients was previously unknown.
Patients and methods
A consecutive series of acute medical admissions to a district general hospital (Ashington Hospital, Northumberland) were screened on admission for raised serum ALP. The reference limits for this laboratory are 30-130 international units (IU) per litre. A level of > 150 lIU/I on admission was defined as raised for the purposes of this study. ALP was measured using para-nitrophenol as substrate in amino methyl propanol buffer (pH 9.3) using a Cobas Bio centrifugal analyser. The within assay coefficient of variation for the method was 1.3% (n = 10) and between assay 2.3% (n = 7). Alkaline phosphatase isoenzyme type was determined by polyacrylamide gel electrophoresis. 6 Measurement of serum alkaline phosphatase was repeated as clinically appropriate and prior to discharge. Patients in whom the cause was not found as an inpatient, whose ALP remained elevated at discharge, were invited to a follow-up clinic dedicated to the purpose of establishing the cause of their raised serum alkaline phosphatase. Investigation both as an inpatient and at the follow-up clinic was directed towards satisfying the diagnostic criteria outlined below by the use of pre-defined investigative pathways. Other causes -these were all well recognized but uncommon causes of raised serum ALP (e.g. non-metastatic hypernephroma, Hodgkin's disease).
Unknown -patients who died (without necropsy) prior to establishing the diagnosis, who failed to attend for follow up after 3 invitations or who failed to meet the diagnostic criteria.
One way analysis of variance and stepwise discriminant analysis were performed using an IBM compatible microcomputer equipped with SOLO statistical software (BMDP Statistical Software, Inc.).7
The study protocol was approved by the local ethical committee.
Results
Two hundred and four of 2884 patients screened had raised serum ALP (7.1%). The major diagnostic categories into which these patients fell is shown in Table I . It can be seen that transient changes in serum alkaline phosphatase activity are common in this group of unselected general medical admissions, heart failure and acute infection being the most frequent diagnoses. However, not all patients who presented initially with either heart failure or acute infection had transiently raised ALP. Twenty-two patients with these initial diagnoses were subsequently shown to have persistently raised ALP due to hepatic metastases (3) and bone disease (8), 11 remained undiagnosed.
In all, 30 of the group with transient hyperphosphatasaemia (all causes) had an acute infection. In 25 of this group the acute infection was the sole illness identified. These 25 patients were accordingly allocated to the transient (infection) group for subsequent analysis. The infections were pneu- Hb-haemoglobin; WCC-white cell count; ESR-erythrocyte sedimentation rate; AST-serum aspartate transaminase; GGT-gamma glutamyl transferase.
group (2) and septicaemia (1). The age of this group did not differ significantly from that of the other groups (Table I) , 3 patients were jaundiced; 12 had raised serum aspartate transaminase (AST), 15 had raised gamma glutamyl transferase (GGT). Twenty of 21 patients in whom it was measured had predominantly liver isoenzyme by polyacrylamide gel electrophoresis.
The biochemical diagnosis of transient hyperphosphatasaemia in association with acute infection was further characterized by one way analysis of variance and discriminant analysis. One way analysis of variance revealed that there were significant differences between groups with respect to white cell count (WCC), erythrocyte sedimentation rate (ESR), serum bilirubin, albumin and GGT (Table I) .
The same haematological and biochemical variables were entered into a series of discriminant analyses comparing the transient (infection) group with the other groups in turn to see if there was a distinguishing pattern of haematological or biochemical results. The 'liver + bone', and 'other' groups were excluded because they contained too few patients for a meaningful comparison to be made and 'no diagnosis' was treated as a missing value for group classification.
For each analysis variables were entered stepwise in order of significant contribution to group membership until all of the unused variables failed to meet the criteria of significance (P < 0.05). The prior probabilities were adjusted according to group size. The linear discriminant functions derived from this analysis were used to classify individual patients and calculate the standard classification merit statistics presented in Table II .
Discussion
This study has shown that raised serum alkaline phosphatase occurs commonly in acutely ill medical inpatients. It emphasizes the observation that transient hyperphosphatasaemia is common in this population. Transient hyperphosphatasaemia is shown to be associated with acute infection in 12% of cases. This group was distinguished from the other major diagnostic groups by the haematological and biochemical features of an acute phase response (raised WCC and ESR, lowered serum albumin) and lower levels of GGT and bilirubin (reflecting the predominance of hepatic dysfunction among the liver and transient (other) groups).
Although inter-individual variation in serum alkaline phosphatase is large (hence the wide reference range), day to day variation within individuals is known to be remarkably small, and assay variation (of 3-5%) accounts for approximately 50% of apparent intrasubject variation for the enzyme.8 For this reason, and the fact that the initial alkaline phosphatase levels in the infected patients were 15% above the normal range when first measured, it is unlikely that the changes in serum alkaline phosphatase activity observed in these infected patients represent random variations or 'regression to the mean'.
It is well recognized that severe infection may be associated with abnormalities of liver function, including mild to moderate increases in serum ALP, bilirubin and transaminases.3 5 These changes may occur in the absence of sepsis in the liver itself' although reports of this phenomenon have largely been confined to patients with jaundice and severe sepsis.9-'2 Isolated raised serum ALP in acute infection is less well recognized.4" 3 GGT-gamma glutamyl transferase; WCC-white cell count.
group.bmj.com on November 7, 2017 -Published by http://pmj.bmj.com/ Downloaded from Abnormal 'liver function tests' were first reported to occur in association with pneumonia in 1950.12 In a study of 94 cases of pneumococcal pneumonia, abnormal bromsulphthalein excretion was found in 81.5%. Thirteen cases developed jaundice but no correlation was found between abnormal liver function tests and conventional measures of severity and outcome. Thirty patients were re-evaluated during convalescence and showed a reversion to normal patterns. Serum enzyme measurements were not made. It was concluded that liver function is widely and almost invariably impaired in pneumonia and suggested that this impairment may be mediated by the 'alarm reaction'.
Raised serum alkaline phosphatase has also been reported in patients with pneumonia4 and in surgical infection.'4 In a study of pneumococcal pneumonia,'5 serum alkaline phosphatase was found to be elevated in 9.4% of the non-jaundiced patients, 23% having raised serum aspartate transaminase. Ten out of 28 patients with jaundice had elevated serum alkaline phosphatase activities. Interpretation of this study is complicated by the high prevalence of glucose-6-phosphatase dehydrogenase deficency, which was present in 85.7% of the jaundiced patients.
Fang reported 4 cases of systemic infection who developed marked elevation of serum alkaline phosphatase in the absence of jaundice.'6 She suggested a number of possible mechanisms by which this might occur, including non-specific effects of bacteria or their toxins, disturbance in transport and clearance ofbilirubin, hepatic anoxia and reduced elimination because of 'reticuloendothelial blockade'.
Kaplan has suggested that alkaline phosphatase may in some circumstances behave as a nonspecific 'acute phase reactant'.'7 This is an attractive hypothesis as it would encompass a number of Fang's possible mechanisms, diverse bacterial infections producing a common effect via the action of the acute phase cytokines. '8 The distinguishing biochemical features of the infected group in this study are entirely consistent with the presence ofan acute phase response. A high ESR, in the absence of immunoglobulin abnormalities is predominantly due to the fibrinogen content of the blood. Fibrinogen is a major positive acute phase reactant protein, showing a 2-to 5-fold rise in plasma concentration during an acute phase response.'9 Similarly, depression of serum albumin level is a well recognized consequence of acute inflammation and is associated with a reduction in hepatic synthesis ofthis protein. 20 The same stimuli that are responsible for alterations in hepatic metabolism (namely interleukin 1, interleukin 6 and tumour necrosis factor-<) also cause the neutrophilia characteristic of acute infection.
Serum alkaline phosphatase may become elevated in other conditions in which the features of an acute phase response are prominent and for which there is currently no explanation. These conditions are aetiologically diverse but share the common features that fever, tissue necrosis or elevated levels of serum acute phase proteins are prominent and well recognized features. Examples include polymyalgia rheumatica,21 non-metastatic hypernephroma with fever,22 surgical infection'2 and retroperitoneal fibrosis. 23 If raised serum alkaline phosphatase is an 'acute phase' phenomenon then there must be a mechanism by which serum alkaline phosphatase of liver type might become elevated during an acute phase response. The accepted mechanism by which hepatic alkaline phosphatase rises in disease is via the action of bile acids in cholestasis.'7 Hepatocyte alkaline phosphatase synthesis is induced by these substances and this process can be demonstrated experimentally in vivo in bile duct ligated animals24 and in vitro, in cultured hepatocytes. 25 No such evidence exists for the action of inflammatory stimuli such as acute phase cytokines in these experimental models, either on biliary uptake and excretion or on hepatocyte alkaline phosphatase activity.
Whatever the mechanism involved, transient hyperphosphatasaemia in association with infection is common in acutely ill medical patients and should be considered before embarking on a search for liver or bone disease in acutely infected patients.
